Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336764 | PMC |
Publication Analysis
Top Keywords
Similar Publications
Author's Reply to ''Comment on 'Prognostic and Clinical Significance of Human Leukocyte Antigen Class I Expression in Breast Cancer: A Meta-Analysis''.
Mol Diagn Ther
January 2025
Department of Breast Surgery, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Jinghua Road No. 24, Luoyang, 471000, China.
Evaluating feature importance biases in logistic regression: Recommendations for Robust Statistical Methods. Author's reply.
Eur J Intern Med
December 2024
Department of Internal Medicine and Pediatrics, Ghent University, Ghent Belgium. Electronic address:
Author's Reply to Pongpirul: "The Pharmaceutical Year that was, 2024".
Pharmaceut Med
December 2024
Pharmaceutical Medicine, London, UK.
'Potent in-vitro activity of sulbactam-durlobactam against NDM-producing Escherichia coli including cefiderocol and aztreonam-avibactam-resistant isolates' - Author's reply.
Clin Microbiol Infect
December 2024
Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland; Swiss National Reference Center for Emerging Antibiotic Resistance, Fribourg, Switzerland. Electronic address:
Author's Reply to Peronard and Mayntz: "SGLT2 Inhibitors, and How They Work Beyond the Glucosuric Effect".
Am J Cardiovasc Drugs
December 2024
Internal Medicine Research Group, Universidad Libre, Cali, Colombia.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!